Adhexpharma

FDA Filings

This page includes the latest FDA filings for Adhexpharma. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Filings

Device Company	Device	Date
Rivastigmine Transdermal System Adhexpharma	Prescription Medication	2024-10-27
Rivastigmine Transdermal System Breckenridge Pharmaceutical, Inc., Adhexpharma	Prescription Medication	2024-03-27
Rivastigmine Transdermal System Adhexpharma	Prescription Medication	2023-10-25
Rivastigmine Transdermal System Adhexpharma	Prescription Medication	2023-01-12
Rivastigmine Transdermal System Adhexpharma	Prescription Medication	2021-01-13
Rivastigmine Transdermal System Breckenridge Pharmaceutical, Inc., Adhexpharma	Prescription Medication	2020-10-28
Rivastigmine Transdermal System Breckenridge Pharmaceutical, Inc., Adhexpharma	Prescription Medication	2020-01-16
Rivastigmine Transdermal System Adhexpharma	Prescription Medication	2019-12-21
NDC 72855-102 Adhexpharma	Rivastigmine Transdermal System	2019-12-19
NDC 72855-101 Adhexpharma	Rivastigmine Transdermal System	2019-12-19
NDC 72855-100 Adhexpharma	Rivastigmine Transdermal System	2019-12-19
Rivastigmine Transdermal System Breckenridge Pharmaceutical, Inc., Adhexpharma	Prescription Medication	2019-12-19

Similar & Related FDA Registered Companies

• Breckenridge Pharmaceutical, Inc.